Mega Lifesciences PCL (BKK:MEGA-R) Change In Payables And Accrued Expense : ฿-349 Mil (TTM As of Mar. 2025)

View and export this data going back to 2013. Start your Free Trial

What is Mega Lifesciences PCL Change In Payables And Accrued Expense?

Mega Lifesciences PCL's Change In Payables And Accrued Expense for the quarter that ended in Mar. 2025 was ฿-359 Mil. It means Mega Lifesciences PCL's Accounts Payable & Accrued Expense declined by ฿359 Mil from Dec. 2024 to Mar. 2025 .

Mega Lifesciences PCL's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2024 was ฿-794 Mil. It means Mega Lifesciences PCL's Accounts Payable & Accrued Expense declined by ฿794 Mil from Dec. 2023 to Dec. 2024 .

Mega Lifesciences PCL Change In Payables And Accrued Expense Historical Data

The historical data trend for Mega Lifesciences PCL's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mega Lifesciences PCL Change In Payables And Accrued Expense Chart

Mega Lifesciences PCL Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

350.29

775.28

693.93

-830.58

-794.16

Mega Lifesciences PCL Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															-804.37	707.57	-354.05	-343.31	-359.23

Mega Lifesciences PCL Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿-349 Mil.

Mega Lifesciences PCL Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Mega Lifesciences PCL's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Mega Lifesciences PCL Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mega Lifesciences PCL (BKK:MEGA-R) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

MEGA:Thailand

Address

Debaratna Road, 909, Ample Tower, 9th Floor, Bangna Nuea, Bangna, Bangkok, THA, 10260

Website

https://www.megawecare.com

Mega Lifesciences PCL manufactures and sells through independent distributors of health food supplements, branded prescription pharmaceutical products, over-the-counter products, herbal products, vitamins, and fast-moving consumer goods as well as provides distribution services relating to such products. The company's product portfolio consists of health food supplements, branded prescription pharmaceutical products, over-the-counter products, herbal products, vitamins, and fast-moving consumer goods. Its segments include Brands in which goods are manufactured and sold under brands owned by the group; Distribution in which the group provides logistical and marketing services for goods trading purposes and sale of goods manufactured by third parties; and OEM.

Mega Lifesciences PCL Headlines

No Headlines